These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21092351)

  • 61. What's in a name? AIDS dementia complex, HIV-associated dementia, HIV-associated neurocognitive disorder or HIV encephalopathy.
    Singh D
    Afr J Psychiatry (Johannesbg); 2012 May; 15(3):172-5. PubMed ID: 22722724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study.
    Pumpradit W; Ananworanich J; Lolak S; Shikuma C; Paul R; Siangphoe U; Chaoniti N; Kaew-On P; Paris R; Ruxrungtham K; Valcour V;
    J Neurovirol; 2010 Feb; 16(1):76-82. PubMed ID: 20053142
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [HIV infection associated cognitive disorders].
    Manea M; Ruşanu V; Patrichi BE; Stoean R; Pădurariu A; Puiu GM
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):598-601. PubMed ID: 20201238
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
    Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cortical neurons are a prominent source of the proinflammatory cytokine osteopontin in HIV-associated neurocognitive disorders.
    Silva K; Hope-Lucas C; White T; Hairston TK; Rameau T; Brown A
    J Neurovirol; 2015 Apr; 21(2):174-85. PubMed ID: 25636782
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals.
    Sacktor N; Skolasky R; Selnes OA; Watters M; Poff P; Shiramizu B; Shikuma C; Valcour V
    J Neurovirol; 2007 Jun; 13(3):203-9. PubMed ID: 17613710
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HIV Dementia Scale and psychomotor slowing--the best methods in screening for neuro-AIDS.
    von Giesen HJ; Haslinger BA; Rohe S; Köller H; Arendt G
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):185-91. PubMed ID: 15939972
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neurological soft signs (NSS) and cognitive deficits in HIV associated neurocognitive disorder.
    Forno G; Henríquez F; Ceballos ME; Gonzalez M; Schröder J; Toro P
    Neuropsychologia; 2020 Sep; 146():107545. PubMed ID: 32593722
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).
    Milanini B; Ciccarelli N; Fabbiani M; Baldonero E; Limiti S; Gagliardini R; Borghetti A; D'Avino A; Mondi A; Colafigli M; Cauda R; Di Giambenedetto S
    Clin Neuropsychol; 2016; 30(sup1):1457-1468. PubMed ID: 27180611
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Applying the HIV-associated neurocognitive disorder diagnostic criteria to HIV-infected youth.
    Hoare J; Phillips N; Joska JA; Paul R; Donald KA; Stein DJ; Thomas KG
    Neurology; 2016 Jul; 87(1):86-93. PubMed ID: 27206720
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa.
    Joska JA; Westgarth-Taylor J; Myer L; Hoare J; Thomas KG; Combrinck M; Paul RH; Stein DJ; Flisher AJ
    AIDS Behav; 2011 Aug; 15(6):1197-203. PubMed ID: 20614176
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Short- and long-term neurocognitive functioning after electroconvulsive therapy in depressed elderly: a prospective naturalistic study.
    Verwijk E; Comijs HC; Kok RM; Spaans HP; Tielkes CE; Scherder EJ; Stek ML
    Int Psychogeriatr; 2014 Feb; 26(2):315-24. PubMed ID: 24280446
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
    Gisslén M; Price RW; Nilsson S
    BMC Infect Dis; 2011 Dec; 11():356. PubMed ID: 22204557
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis.
    Ayesa-Arriola R; Pérez-Iglesias R; Rodríguez-Sánchez JM; Pardo-García G; Tabares-Seisdedos R; Ayuso-Mateos JL; Vázquez-Barquero JL; Crespo-Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():23-8. PubMed ID: 23228461
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
    Polgár P
    Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuropsychological impairment in veterans who are HIV-positive.
    Grohman K; Donnelly K; Strang J; Kleiner J
    Brain Cogn; 2002 Jul; 49(2):194-8. PubMed ID: 15259387
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.
    Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA
    AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.